GlassScriptPhysician profile
Jamshid Faraji
NPI 1932125382
$9,636.36
in general payments reported to CMS, 2019-2025
39 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,464 · 2020: $1,115 · 2021: $1,257 · 2022: $1,650 · 2023: $1,438 · 2024: $590 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,070 · Education: $79.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,070.35 |
| Education | $79.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,070.82 | 2019-2024 | Farxiga, Lokelma, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,002.11 | 2019-2024 | Ofev, Synjardy, Jardiance |
| Glaxosmithkline, LLC. | $961.97 | 2019-2025 | Trelegy Ellipta, Nucala |
| Amarin Pharma, INC. | $809.27 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $686.78 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $531.20 | 2019-2023 | Verquvo, Steglatro, Belsomra |
| Novartis Pharmaceuticals Corporation | $321.50 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $319.52 | 2019-2022 | |
| Lilly USA, LLC | $308.45 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $302.59 | 2019 | |
| Pfizer INC. | $283.66 | 2019-2021 | |
| Amgen INC. | $259.07 | 2021-2024 | Prolia, Evenity, Otezla |
| Novo Nordisk INC | $256.52 | 2020-2022 | |
| Medtronic, INC. | $250.99 | 2022-2023 | Intellis Adaptivestim |
| Allergan, INC. | $248.49 | 2019 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamshid Faraji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.